1. Home
  2. XERS vs GCT Comparison

XERS vs GCT Comparison

Compare XERS & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • GCT
  • Stock Information
  • Founded
  • XERS 2005
  • GCT 2019
  • Country
  • XERS United States
  • GCT United States
  • Employees
  • XERS N/A
  • GCT N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • XERS Health Care
  • GCT Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • GCT Nasdaq
  • Market Cap
  • XERS 1.3B
  • GCT 1.0B
  • IPO Year
  • XERS 2018
  • GCT 2022
  • Fundamental
  • Price
  • XERS $9.25
  • GCT $26.65
  • Analyst Decision
  • XERS Strong Buy
  • GCT Buy
  • Analyst Count
  • XERS 7
  • GCT 2
  • Target Price
  • XERS $8.00
  • GCT $24.00
  • AVG Volume (30 Days)
  • XERS 2.2M
  • GCT 778.7K
  • Earning Date
  • XERS 11-07-2025
  • GCT 11-06-2025
  • Dividend Yield
  • XERS N/A
  • GCT N/A
  • EPS Growth
  • XERS N/A
  • GCT 19.25
  • EPS
  • XERS N/A
  • GCT 3.31
  • Revenue
  • XERS $246,025,000.00
  • GCT $1,193,610,000.00
  • Revenue This Year
  • XERS $43.89
  • GCT $4.65
  • Revenue Next Year
  • XERS $20.40
  • GCT $4.94
  • P/E Ratio
  • XERS N/A
  • GCT $8.04
  • Revenue Growth
  • XERS 35.62
  • GCT 21.20
  • 52 Week Low
  • XERS $2.82
  • GCT $11.17
  • 52 Week High
  • XERS $9.41
  • GCT $34.50
  • Technical
  • Relative Strength Index (RSI)
  • XERS 69.43
  • GCT 43.69
  • Support Level
  • XERS $7.78
  • GCT $25.80
  • Resistance Level
  • XERS $8.46
  • GCT $28.88
  • Average True Range (ATR)
  • XERS 0.41
  • GCT 1.48
  • MACD
  • XERS 0.09
  • GCT -0.23
  • Stochastic Oscillator
  • XERS 90.32
  • GCT 24.30

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: